Press Releases 2019

Back
  • Fraunhofer IBMT in the visionary EU-FET Open Project AMPHORA / 2019

    New approaches for a more precise radiation therapy of cancer

    Press Release / 6.8.2019

    Ultrasound expertise of the Fraunhofer Institute for Biomedical Engineering IBMT in the visionary EU-FET Open Project AMPHORA (Acoustic markers for enhanced remote sensing of radiation doses).

    more info
  • © Fraunhofer EMFT, Bernd Müller.

    In the ViroSens project, researchers from the Fraunhofer-Gesellschaft in Sulzbach and Regensburg are working together with industrial partners on a novel analytical method to make the potency testing of vaccines more efficient and cost-effective. The method combines electrochemical sensor technology and biotechnology and, for the first time, enables a completely automated analysis of the infection status of test cells.

    more info
  • A transdisciplinary approach with bio-nanodevice interfaces / 2019

    GLADIATOR - New technologies for cancer monitoring and therapy

    Press Release / 3.6.2019

    The Fraunhofer Institute for Biomedical Engineering IBMT is contributing its expertise in the field of medical biotechnology and ultrasound to a new EC project to work on the next generation of theranostics for brain pathologies using autonomous externally controllable nanonetworks.

    more info
  • © Fraunhofer IBMT, Photo: Bernd Müller.

    Application-specific high-throughput stem cell production processes revolutionize industrial new drug testing. For biotechnological and pharmaceutical companies, the development of cell culture automation using innovative materials is a promising approach to optimize existing processes. By customized material characteristics, expansion and/or differentiation of human stem cells (with focus on human induced pluripotent stem cells, hiPSCs) shall be positively influenced and automated solutions for the production for high-qualitative cells shall be developed. These generated cells can then be used for the production of model systems for drug tests, toxicity studies or disease modelling, thus providing e. g., a major contribution to personalized medicine or the avoidance of animal experiments.

    more info
  • © Fraunhofer IBMT, Bernd Müller.

    Together, the Fraunhofer Institute for Biomedical Engineering IBMT, the Fraunhofer Institute for Applied Information Technology FIT and the Fraunhofer Project Center for Stem Cell Process Engineering SPT present selected topics of laboratory technology and biotechnology in the mobile epidemiological BSL2 laboratory, the so-called »mobile EpiLab«.

    more info
  • EBiSC2 will secure long-term access to well characterised and quality-controlled hiPSCs for academic and commercial researchers worldwide, continuing to support R&D activities such as disease modelling and drug discovery.

    more info
  • Project network provides innovative IT platform for clinical data integration, model development and validation / 2019

    Personalized Medicine: Effective through Artificial Intelligence in Transplantation Medicine - New Prediction Models for Disease Progression Developed

    Press Release / 5.3.2019

    © AdobeStock_126446055

    If radiation or chemotherapy treatment of leukaemias or lymphomas does not bring sufficient success, the transplantation of bone marrow or blood stem cells is usually the only chance of cure. Unfortunately, the majority of patients die despite transplantation, often due to spontaneous infections, transplant versus recipient reactions and recurrences. New predictive models for the individual course of disease, as developed in the "XplOit" research project, predict the occurrence and extent of these risks and thus enable transplantation physicians to intervene at an early stage to save lives in dreaded complications.

    more info
  • Laboratories of the Main Department Medical Biotechnology of the Fraunhofer Institute for Biomedical Engineering IBMT certified and accredited / 2019

    Committed to the Highest Quality

    Press Release / 1.3.2019

    Since mid-February 2019, the laboratories of the Main Department of Medical Biotechnology in Sulzbach are now also GLP certified. In Saarland, the Ministry of the Environment and Consumer Protection is responsible for issuing a GLP certificate in accordance with § 19b (1) of the Chemicals Act.

    more info